Deacetylase inhibitors CM-444 and CM-1758 enhance chemotherapy response in AML via ALOX5.

Gimenez-Camino N, San José-Enériz E, Garate L, Miranda E, Sáez E, Pineda-Lucena A, Prósper F, Agirre X

Open source

DOI
10.1111/bjh.70520
Published
2026 Jul
Container
British journal of haematology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bjh.70520,
  title = {Deacetylase inhibitors CM-444 and CM-1758 enhance chemotherapy response in AML via ALOX5.},
  author = {Gimenez-Camino N and San José-Enériz E and Garate L and Miranda E and Sáez E and Pineda-Lucena A and Prósper F and Agirre X},
  year = {2026},
  journal = {British journal of haematology},
  doi = {10.1111/bjh.70520},
  url = {https://doi.org/10.1111/bjh.70520}
}

RIS

TY  - JOUR
TI  - Deacetylase inhibitors CM-444 and CM-1758 enhance chemotherapy response in AML via ALOX5.
AU  - Gimenez-Camino N
AU  - San José-Enériz E
AU  - Garate L
AU  - Miranda E
AU  - Sáez E
AU  - Pineda-Lucena A
AU  - Prósper F
AU  - Agirre X
PY  - 2026
JO  - British journal of haematology
DO  - 10.1111/bjh.70520
UR  - https://doi.org/10.1111/bjh.70520
ER  - 

APA

N, G., E, S. J., L, G., E, M., E, S., A, P., F, P., & X, A. (2026). Deacetylase inhibitors CM-444 and CM-1758 enhance chemotherapy response in AML via ALOX5.. British journal of haematology. https://doi.org/10.1111/bjh.70520

Source records